Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus-based Steroid Withdrawal in Renal Transplant
NCT00133172Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Jul 2005
- Primary completion
- Mar 2007
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Astellas Pharma. Started Jul 2005; status: terminated.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00133172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133172.